The Spreading Cancer of Counterfeit Drugs

Peter Pitts
President, Center for Medicine in the Public Interest

DOI:https://doi.org/10.5912/jcb940

Abstract:

Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines – with their high-speed “host” being the digitization of patient care. The future is now. So, how do we balance moving forward with user-friendly digitization, telemedicine and virtual healthcare delivery while simultaneously recognizing the unintended consequences of the innovative criminal mind? The first step is to recognize there’s a problem.